Clinical Trial Update: Firibastat in Treatment-resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for firibastat in treatment-resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Firibastat (firibastat)

Snippet

Sponsor: Quantum Genomics SA | Conditions: Hypertension | Phase 3 | Status: COMPLETED